RSS

European League Against Rheumatism (EULAR)

Novartis has announced that important new data will be presented on secukinumab in ankylosing spondylitis at the forthcoming European League Against Rheumatism 2015 Annual Scientific Meeting, from 10–13 June, in Rome, Italy. more

News